U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Rize Vapor - 04/13/2017
  1. Warning Letters

CLOSEOUT LETTER

Rize Vapor

Recipient:
Rize Vapor

United States

Issuing Office:

United States

  

Department of Health and Human Services logo

 
 
Center for Tobacco Products
10903 New Hampshire Avenue
Silver Spring, MD 20993 

APR 13, 2017

VIA Electronic Mail

Rize Vapor
Attn: Frank Colombo
info@rizevapor.com
Fc2020@hotmail.com

Dear Frank Colombo:

The United States Food and Drug Administration's (FDA) Center for Tobacco Products has completed an evaluation of your corrective actions included in your letter dated October 18, 2016, in response to our Warning Letter dated September 29, 2016. Based on our evaluation, it appears that you have taken steps to address the violation contained in the Warning Letter for the website http://www.rizevapor.com.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to ensure compliance with the Federal Food, Drug, and Cosmetic Act and its im plementing regulations or with other relevant legal authority. This letter also will not preclude any regulatory action should violations be observed in the future.

Sincerely,
/S/

Bryan Hills
Branch Chief
Division of Promotion, Advertising, and Labeling
Office of Compliance and Enforcement
Center for Tobacco Products

VIA Electronic Mail

cc:

GoDaddy.Com, LLC
abuse@godaddy.com

3dCart Shopping Cart Software
Attn: Gonzalo J. Gil
gil@3dcart.com
 

Back to Top